FOI release

Freedom of Information responses from the MHRA - week commencing 16 May 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 16 May 2022

• From: Medicines and Healthcare products Regulatory Agency
• Published: 27 March 2023

Documents

Freedom of Information request on the number of 150-day applications have been submitted (FOI 22/467)

HTML

Freedom of Information request on the clinical details of the suspected adverse reactions of lens opacities with cystic fibrosis transmembrane conductance regulator modulators (FOI /614)

HTML

FOI-22-614-1

PDF, 83.3 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request on the COVID-19 vaccines and lateral flow tests (FOI 22/649)

HTML

Freedom of Information request on the yellow card reports submitted for ctroconvulsive Therapy devices over the past 5 years

HTML

Freedom of Information request on list of all GP practices that contribute patient date to the Clinical Practice Research Datalink (FOI 22/700)

HTML

Freedom of Information request on MHRA staffing for inspectors between November 2021 and March 2022 (FOI 22/468)

HTML

Freedom of Information request on the meetings of the Opioid Expert Working Group of the Commission on Human Medicines since April 2019 (FOI 22/625)

HTML

Freedom of Information request on the adverse reactions reported for avesical Bacillus Calmette Guérrin (FOI 22/628)

HTML

Freedom of Information request on the IT contracts (FOI 22/675)

HTML

Freedom of Information request on the rolling review of the Valneva COVID-19 vaccine (FOI 22/691)

HTML

Freedom of Information request on the adverse reactions reported relating to Aripiprazole (FOI 22/694)

HTML

Freedom of Information request on the number of organisations that have licensed data from CPRD from 2018-2022 (FOI 22/707)

HTML

Details

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 16 May 2022

Published 27 March 2023